https://investor.ironwoodpharma.com/press-releases/press-release-details/2024/Ironwood-Late-Breaker-Oral-Presentation-at-Digestive-Disease-Week-Reinforces-Potential-of-Once-Weekly-Apraglutide-for-Adults-with-Short-Bowel-Syndrome-with-Intestinal-Failure-SBS-IF/default.aspx